MAMLD1 Gene Hypospadias Type 2 X-linked Genetic Test
Test Name: MAMLD1 Gene Hypospadias Type 2 X-linked Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Reproductive Disorders
Doctor: Gynecology
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for MAMLD1 Gene Hypospadias Type 2, X-linked NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAMLD1 Gene Hypospadias Type 2, X-linked NGS Genetic DNA Test gene MAMLD1
Test Details
The MAMLD1 gene is associated with a condition called hypospadias type 2, which is a congenital abnormality affecting the development of the urethra in males. This condition is inherited in an X-linked manner, meaning it is caused by mutations in the MAMLD1 gene located on the X chromosome.
To diagnose hypospadias type 2 and identify any mutations in the MAMLD1 gene, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or even the entire exome (all protein-coding genes) in a cost-effective manner.
During the NGS test, a sample of DNA is extracted, usually from blood or saliva, and prepared for sequencing. The DNA is then fragmented and amplified to generate millions of short DNA fragments. These fragments are sequenced using NGS technology, and the resulting sequence data is analyzed to identify any variations or mutations in the MAMLD1 gene.
By performing an NGS genetic test, clinicians can determine if a patient has any mutations in the MAMLD1 gene that are associated with hypospadias type 2. This information can help in confirming a diagnosis, understanding the genetic basis of the condition, and providing appropriate genetic counseling and management for affected individuals and their families.
| Test Name | MAMLD1 Gene Hypospadias type 2 X-linked Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Reproductive Disorders |
| Doctor | Gynecology |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for MAMLD1 Gene Hypospadias type 2, X-linked NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with MAMLD1 Gene Hypospadias type 2, X-linked NGS Genetic DNA Test gene MAMLD1 |
| Test Details |
The MAMLD1 gene is associated with a condition called hypospadias type 2, which is a congenital abnormality affecting the development of the urethra in males. This condition is inherited in an X-linked manner, meaning it is caused by mutations in the MAMLD1 gene located on the X chromosome. To diagnose hypospadias type 2 and identify any mutations in the MAMLD1 gene, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput DNA sequencing technology that allows for the simultaneous sequencing of multiple genes or even the entire exome (all protein-coding genes) in a cost-effective manner. During the NGS test, a sample of DNA is extracted, usually from blood or saliva, and prepared for sequencing. The DNA is then fragmented and amplified to generate millions of short DNA fragments. These fragments are sequenced using NGS technology, and the resulting sequence data is analyzed to identify any variations or mutations in the MAMLD1 gene. By performing an NGS genetic test, clinicians can determine if a patient has any mutations in the MAMLD1 gene that are associated with hypospadias type 2. This information can help in confirming a diagnosis, understanding the genetic basis of the condition, and providing appropriate genetic counseling and management for affected individuals and their families. |
